National Tuberculosis Control Program; Mycobacterial Disease Control National AIDS/STD Program
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Please download the complete toolkit directly from the website (large size: 24 MB)
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Documentos Téchnico Normativos
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Key populations brief
Accessed November 2017
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The new, all oral, 20-month MDR-TB regimens range from US $1,600* (using bedaquiline and linezolid for 6 months and levofloxacin as the fluoroquinolone) to US $2,100* (using linezolid for 12 months and moxifloxacin as the fluoroquinolone.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Technical information note. Digital Adherence Technologies (DATs) such as the smart medication container
kit can help to support people affected by TB with their treatment in a modern
and ef-fective way. These technologies are able to deliver reminders and may
help em-power TB affected individual...s and their families to take their daily
medication at a time and place that suits them best. They also generate a
digital record of medication intake.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                TB policies in 29 Countries
A survey of prevention, testing and treatment policies and practices
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Rapport sur les populations clès
Accessed November 2017
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Key populations brief
Accessed 2017
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Rapport sur les populations clés.
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Towards a world free of tuberculosis